ROBERT ALEXANDER INGRAM
CIK 1219890 · last filed 2023-03-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$7.76M
Companies
11
Total Filings
307
Lifetime Open-Market Net
-$8.30M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BCRX | Director | 100,198 | $8.70 | $871.7K | $29.0K | 32 | 2023-03-02 |
| BDTX | Director | 42,854 | $1.75 | $75.0K | $152.3K | 12 | 2022-12-19 |
| Novan, Inc. (NOVN) Delisted | Director | 169,777 | $0.09 | $16.0K | $307.3K | 9 | 2020-07-30 |
| WOLFSPEED, INC. (CREE) Delisted | Director | 77,710 | $79.12 | $6.15M | -$84.8K | 47 | 2018-10-18 |
| REGN | Director | 6,667 | $612.14 | $4.08M | -$708.0K | 2 | 2015-05-27 |
| EW | Director | 32,062 | $85.11 | $2.73M | -$3.95M | 14 | 2015-05-19 |
| ALLERGAN INC (AGN) Delisted | Director | 19,382 | — | — | -$1.22M | 72 | 2012-10-31 |
| PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Director | 0 | — | — | $0 | 2 | 2011-12-06 |
| LOWES COMPANIES INC (LOWw) Delisted | Director | 8,000 | — | — | -$388.9K | 24 | 2011-04-04 |
| VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Director | 0 | — | — | $0 | 39 | 2010-09-30 |
| OSI PHARMACEUTICALS INC (OSIP) Delisted | Director | 0 | — | — | -$2.44M | 9 | 2010-06-09 |
Recent Filings · Page 4 of 31
307 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-11-18 | BCRX | Buy (P) | +20,000 | $29.0K | EDGAR |
| 2019-09-04 | BCRX | Grant (A) | +6,270 | $18.7K | EDGAR |
| 2019-08-02 | Novan, Inc. (NOVN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-31 | BCRX | Grant (A) | — | $0 | EDGAR |
| 2019-05-23 | Novan, Inc. (NOVN) Delisted | Buy (P) | +50,000 | $110.5K | EDGAR |
| 2018-10-18 | WOLFSPEED, INC. (CREE) Delisted | Grant (A) | +760 | $30.0K | EDGAR |
| 2018-10-01 | Novan, Inc. (NOVN) Delisted | Buy (P) | +50,000 | $142.0K | EDGAR |
| 2018-08-31 | WOLFSPEED, INC. (CREE) Delisted | Exer (M) | +4,000 | $123.7K | EDGAR |
| 2018-08-16 | WOLFSPEED, INC. (CREE) Delisted | Grant (A) | +648 | $30.0K | EDGAR |
| 2018-06-22 | BCRX | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.